JP2006501215A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006501215A5 JP2006501215A5 JP2004527226A JP2004527226A JP2006501215A5 JP 2006501215 A5 JP2006501215 A5 JP 2006501215A5 JP 2004527226 A JP2004527226 A JP 2004527226A JP 2004527226 A JP2004527226 A JP 2004527226A JP 2006501215 A5 JP2006501215 A5 JP 2006501215A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- treating
- rheumatoid arthritis
- osteoarthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40304002P | 2002-08-13 | 2002-08-13 | |
| PCT/IB2003/003613 WO2004014892A1 (en) | 2002-08-13 | 2003-08-03 | Monocyclic derivatives as matrix metalloproteinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006501215A JP2006501215A (ja) | 2006-01-12 |
| JP2006501215A5 true JP2006501215A5 (enExample) | 2006-09-14 |
Family
ID=31715927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004527226A Pending JP2006501215A (ja) | 2002-08-13 | 2003-08-03 | マトリックスメタロプロテイナーゼ阻害剤としての単環式誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7132424B2 (enExample) |
| EP (1) | EP1537098A1 (enExample) |
| JP (1) | JP2006501215A (enExample) |
| AU (1) | AU2003253176A1 (enExample) |
| BR (1) | BR0313459A (enExample) |
| CA (1) | CA2494014A1 (enExample) |
| MX (1) | MXPA05001603A (enExample) |
| WO (1) | WO2004014892A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1434585A1 (en) | 2001-10-12 | 2004-07-07 | Warner-Lambert Company LLC | Alkyne matrix metalloproteinase inhibitors |
| WO2003106381A2 (en) | 2002-06-12 | 2003-12-24 | Exelixis, Inc. | Human adam-10 inhibitors |
| EP1394159A1 (fr) * | 2002-08-13 | 2004-03-03 | Warner-Lambert Company LLC | Nouveaux dérivés de thiophène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent |
| PA8578101A1 (es) * | 2002-08-13 | 2004-05-07 | Warner Lambert Co | Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz |
| US20040142950A1 (en) * | 2003-01-17 | 2004-07-22 | Bunker Amy Mae | Amide and ester matrix metalloproteinase inhibitors |
| US20060247231A1 (en) * | 2003-12-18 | 2006-11-02 | Warner-Lambert Company Llc | Amide and ester matrix metalloproteinase inhibitors |
| ES2524922T3 (es) | 2005-05-10 | 2014-12-15 | Intermune, Inc. | Derivados de piridona para modular el sistema de proteína cinasa activada por estrés |
| JP5627574B2 (ja) | 2008-06-03 | 2014-11-19 | インターミューン， インコーポレイテッド | 炎症性および線維性疾患を治療するための化合物および方法 |
| WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| EP2934539B1 (en) | 2012-12-20 | 2019-03-27 | Merck Sharp & Dohme Corp. | C5, c6 oxacyclic-fused iminothiazine dioxide compounds as bace inhibitors |
| WO2014099788A1 (en) * | 2012-12-21 | 2014-06-26 | Merck Sharp & Dohme Corp. | C5-spiro iminothiadiazine dioxides as bace inhibitors |
| MX382781B (es) | 2014-04-02 | 2025-03-13 | Intermune Inc | Piridinonas anti-fibroticas. |
| EP3693369A3 (en) | 2016-04-15 | 2020-09-09 | AbbVie Inc. | Bromodomain inhibitors |
| CN117777121A (zh) | 2016-10-24 | 2024-03-29 | 詹森药业有限公司 | 化合物及其用途 |
| EA201991650A1 (ru) | 2017-01-06 | 2020-01-20 | Юманити Терапьютикс, Инк. | Способы лечения неврологических расстройств |
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES THEREOF |
| AU2019238326B2 (en) | 2018-03-23 | 2025-03-06 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| JP7742775B2 (ja) | 2019-01-24 | 2025-09-22 | ヤンセン ファーマシューティカ エヌ．ベー． | 化合物及びその使用 |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| WO2024196136A1 (ko) * | 2023-03-21 | 2024-09-26 | 주식회사 비보존 | Mglur5 및 hdac6의 이중 조절제 및 이의 용도 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2650223A (en) * | 1950-08-08 | 1953-08-25 | Abbott Lab | 2,5-diketopiperazines |
| DE1029001B (de) * | 1956-06-30 | 1958-04-30 | Basf Ag | Verfahren zur Herstellung von basisch substituierten Derivaten des Pyridazinons-(3) |
| DE3825468A1 (de) * | 1988-07-27 | 1990-02-01 | Basf Ag | 5-amino-6-pyridazonderivate, verfahren zu ihrer herstellung und sie enthaltende herbizide mittel |
| US5425289A (en) | 1993-10-21 | 1995-06-20 | Snap-On Incorporated | Bung tool |
| DE3931432A1 (de) | 1989-09-21 | 1991-04-04 | Hoechst Ag | Pyrimidin-4,6-dicarbonsaeurediamide, verfahren zu deren herstellung sowie verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| US5260323A (en) | 1990-06-28 | 1993-11-09 | Hoechst Aktiengesellschaft | 2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use |
| EP0541042A1 (de) | 1991-11-05 | 1993-05-12 | Hoechst Aktiengesellschaft | Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
| US6008243A (en) | 1996-10-24 | 1999-12-28 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use |
| JPH11199512A (ja) | 1997-10-24 | 1999-07-27 | Pfizer Prod Inc | 変形性関節症および他のｍｍｐ媒介疾患の治療のためのｍｍｐ−１３選択的阻害剤の使用 |
| UA59453C2 (uk) | 1998-08-12 | 2003-09-15 | Пфайзер Продактс Інк. | Похідні гідроксипіпеколат гідроксамової кислоти як інгібітори матричних металопротеїназ |
| AR022423A1 (es) * | 1999-01-27 | 2002-09-04 | American Cyanamid Co | Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento |
| PA8498701A1 (es) * | 1999-08-12 | 2002-08-26 | Pfizer Prod Inc | Pirimidina-2,4,6-trionas inhibidores de metaloproteinasas |
| US6934639B1 (en) | 2000-02-25 | 2005-08-23 | Wyeth | Methods for designing agents that interact with MMP-13 |
| EP1138680A1 (en) | 2000-03-29 | 2001-10-04 | Pfizer Products Inc. | Gem substituted sulfonyl hydroxamic acids as MMP inhibitors |
| WO2002034753A2 (en) * | 2000-10-26 | 2002-05-02 | Pfizer Products Inc. | Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| WO2002034726A2 (en) | 2000-10-26 | 2002-05-02 | Pfizer Products Inc. | Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| PA8539401A1 (es) | 2001-02-14 | 2002-10-28 | Warner Lambert Co | Quinazolinas como inhibidores de mmp-13 |
| PA8539501A1 (es) | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Compuestos triazolo como inhibidores de mmp |
| WO2002064571A1 (en) | 2001-02-14 | 2002-08-22 | Warner-Lambert Company Llc | Pyrimidine matrix metalloproteinase inhibitors |
| DOP2002000333A (es) | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Derivados de acido isoftalico como inhibidores de metaloproteinasas de la matriz |
| DOP2002000334A (es) | 2001-02-14 | 2002-08-30 | Warner Lambert Co | Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz |
| PA8539301A1 (es) | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Inhibidores de la metaloproteinasa de la matriz |
| DOP2002000332A (es) * | 2001-02-14 | 2002-08-30 | Warner Lambert Co | Inhibidores de piridina de metaloproteinasas de la matriz |
| CA2433075A1 (en) * | 2001-02-14 | 2002-08-22 | Michael William Wilson | Benzo thiadiazine matrix metalloproteinase inhibitors |
| WO2002064598A1 (en) | 2001-02-14 | 2002-08-22 | Warner-Lambert Company Llc | Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| US6924276B2 (en) | 2001-09-10 | 2005-08-02 | Warner-Lambert Company | Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| BR0213239A (pt) | 2001-10-12 | 2004-09-28 | Warner Lambert Co | Compostos de pirimidina com anel condensado alcinilado como inibidores da metalo-proteinase da matriz de tipo 13 |
| EP1434585A1 (en) | 2001-10-12 | 2004-07-07 | Warner-Lambert Company LLC | Alkyne matrix metalloproteinase inhibitors |
| US6962922B2 (en) * | 2001-10-12 | 2005-11-08 | Warner-Lambert Company Llc | Alkynylated quinazoline compounds |
| US6933298B2 (en) | 2001-12-08 | 2005-08-23 | Aventis Pharma Deutschland Gmbh | Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases |
| US6700540B2 (en) * | 2002-02-14 | 2004-03-02 | Ericsson, Inc. | Antennas having multiple resonant frequency bands and wireless terminals incorporating the same |
| US6894057B2 (en) | 2002-03-08 | 2005-05-17 | Warner-Lambert Company | Oxo-azabicyclic compounds |
| WO2003076416A1 (en) | 2002-03-08 | 2003-09-18 | Warner-Lambert Company Llc | Oxo azabicyclic compounds |
| US6747147B2 (en) | 2002-03-08 | 2004-06-08 | Warner-Lambert Company | Oxo-azabicyclic compounds |
| WO2004000321A1 (en) | 2002-06-25 | 2003-12-31 | Warner-Lambert Company Llc | Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| US20040006077A1 (en) | 2002-06-25 | 2004-01-08 | Bernard Gaudilliere | Thiazine and oxazine derivatives as MMP-13 inhibitors |
-
2003
- 2003-08-03 BR BR0313459-8A patent/BR0313459A/pt not_active IP Right Cessation
- 2003-08-03 MX MXPA05001603A patent/MXPA05001603A/es not_active Application Discontinuation
- 2003-08-03 WO PCT/IB2003/003613 patent/WO2004014892A1/en not_active Ceased
- 2003-08-03 CA CA002494014A patent/CA2494014A1/en not_active Abandoned
- 2003-08-03 AU AU2003253176A patent/AU2003253176A1/en not_active Abandoned
- 2003-08-03 EP EP03784414A patent/EP1537098A1/en not_active Withdrawn
- 2003-08-03 JP JP2004527226A patent/JP2006501215A/ja active Pending
- 2003-08-05 US US10/634,713 patent/US7132424B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006501215A5 (enExample) | ||
| NO2014009I2 (no) | Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser | |
| EP2049710A4 (en) | MASTER ELECTRODE AND METHOD OF MANUFACTURING THEREOF | |
| LU92307I2 (fr) | Elviégravir sous toutes ses formes comme protégéespar le brevet de base | |
| DE60334379D1 (de) | Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung | |
| EP1857425A4 (en) | PIEZOELECTRIC CERAMIC COMPOSITION AND MANUFACTURING METHOD THEREFOR | |
| PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
| FR2895406B1 (fr) | Procede pour la fabrication de 2,3-dimethylbut-1-ene | |
| FR2874836B1 (fr) | Procede d'enrobage de poudres | |
| JP2005532458A5 (enExample) | ||
| JP2003284553A5 (enExample) | ||
| FR2854078B1 (fr) | Procede de fabrication d'une composition therapeutique immuno-stimulante. | |
| FR2894772B1 (fr) | Procede d'enrichissement en dha | |
| EP1717258A4 (en) | DIHALOGENIDE, POLYMER CONNECTION AND MANUFACTURING METHOD THEREFOR | |
| FR2890959B1 (fr) | Procede de preparation d'une composition de platre. | |
| FR2869030B1 (fr) | Procede de production d'alpha-alumine particulaire | |
| EP1883628A4 (en) | IMPROVED PROCESS FOR THE PREPARATION OF 3,5-DIETHYL-1,2-DIHYDRO-1-PHENYL-2-PROPYLPYRIDINE | |
| FR2890654B1 (fr) | Procede de preparation d'une composition humique artificielle, et applications | |
| JP2003501382A5 (enExample) | ||
| FR2888843B1 (fr) | Procede de preparation d'un diarylanthracene. | |
| BRPI0410638A (pt) | derivados de azitromicina | |
| ITMI20030827A1 (it) | Composizione farmaceutica contenente l'associazione levodopa/carbidopa. | |
| ITMI20030826A1 (it) | Composizione farmaceutica contenente interferone per il | |
| ITRM20030442A0 (it) | Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia. | |
| FR2892012B1 (fr) | Procede d'epilation |